[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355269-105":59,"doc-detail-355269-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-epigenetic-therapy-for-esophageal-cancer","Advances in epigenetic therapy for esophageal cancer","","Esophageal cancer is a highly aggressive malignancy with substantial heterogeneity in its underlying mechanisms and clinical behavior. Although surgery, chemotherapy, and radiotherapy have improved some outcomes, prognosis remains poor. Growing evidence indicates that epigenetic regulation is central to tumor initiation and progression. Epigenetic mechanisms such as DNA methylation, histone modification, and non-coding RNA can control gene expression without changing DNA sequence, affecting proliferation, apoptosis, and invasion, and providing biomarkers and therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-epigenetic-therapy-for-esophageal-cancer/355269/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-epigenetic-therapy-for-esophageal-cancer/355269.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does esophageal cancer have poor prognosis despite current treatments?","Question",{"text":112,"@type":113},"Despite progress with surgery, chemotherapy, and radiotherapy, effectiveness is still limited in advanced disease and many patients are diagnosed at advanced stages, making outcomes poor.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which epigenetic mechanisms are highlighted as important in esophageal cancer?",{"text":117,"@type":113},"DNA methylation, histone modifications, and non-coding RNAs are emphasized as key regulatory processes involved in tumor biology.",{"name":119,"@type":110,"acceptedAnswer":120},"How can epigenetic therapy contribute to treatment options for esophageal cancer?",{"text":121,"@type":113},"Epigenetic therapies modulate gene expression without changing the DNA sequence, influencing cancer processes such as proliferation, apoptosis, and metastasis, and may provide new therapeutic targets and biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355269,1791045895,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Ye et al. Clinical Epigenetics (2026) 18:42 [https://doi.org/10.1186/s13148-026-02073-5](https://doi.org/10.1186/s13148-026-02073-5)  \nClinical Epigenetics  \nREVIEW Open Access  \nAdvances in epigenetic therapy for esophageal cancer  \nCheng Ye1, Xinxin Yan1 and Yang Gao1*  \nAbstract  \nEsophageal cancer is a highly aggressive malignant tumor of the digestive tract, with significant heterogeneity in its pathogenesis and clinical manifestations. Despite advances in treatment strategies such as surgery, chemotherapy, and radiotherapy, the prognosis of esophageal cancer remains poor. In recent years, increasing evidence has shown that epigenetic regulation plays a critical role in the occurrence and development of esophageal cancer. Epigenetic mechanisms, including DNA methylation, histone modification, and non-coding RNA, can regulate gene expression without changing the DNA sequence and are involved in a variety of biological processes, including cell proliferation, apoptosis, and invasion. Abnormal epigenetic alterations are not only key drivers of tumorigenesis but also promising biomarkers and therapeutic targets. This review focuses on the epigenetic mechanisms involved in esophageal cancer and summarizes the latest progress in epigenetic-based therapeutic strategies, includingthe development and application of DNA methyltransferase inhibitors, histone deacetylase inhibitors, and drugs targeting non-coding RNAs. Moreover, it discusses the challenges and future prospects of epigenetic therapy in the clinical management of esophageal cancer.  \nKeywords Epigenetic therapy, Esophageal cancer, DNA methylation, Histone modification, Non-coding RNA, Chromatin remodeling.  \nIntroduction  \nEsophageal cancer (EC) is a common malignancy worldwide, with a rising incidence and mortality rate that has garnered increasing global attention. According to the World Health Organization (WHO), approximately 600,000 new cases of esophageal cancer are diagnosed annually, with nearly half occurring in China, making it one of the most affected regions globally [1, 2]. In the United States, data from the American Cancer Society suggest a steadily increasing incidence, with an estimated  \n†Ye Cheng andYan Xinxin have contributed equally to this work.  \n*Correspondence: Yang Gao [gaoyang@stu.edu.cn](gaoyang@stu.edu.cn)  \n1Department of Histology and Embryology, Shantou University Medical College, Shantou, China  \n26,000 new cases expected in 2024 [3]. The development of esophageal cancer is associated with various risk factors, including prolonged exposure to irritants such as tobacco and alcohol, as well as chronic gastroesophageal reflux disease (GERD) [4–6]. Due to its insidious onset and rapid progression, most patients are diagnosed at an advanced stage, posing significant challenges for effective treatment [7].  \nConventional treatments such as surgery, radiotherapy, and chemotherapy have achieved some improvement in patient outcomes; however, their effectiveness is still limited in advanced esophageal cancer. For early-stage esophageal cancer, surgical resection remains a relatively effective option, offering the potential for cure by removing the tumor and surrounding tissues. However, for advanced cases in which the cancer has spread to lymph nodes or distant organs, surgery is often not feasible or  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons lic","cbCaiufUDzChazS4","https://ap.wps.com/l/cbCaiufUDzChazS4","pdf",1315639,12,"English","# Abstract\n# Introduction\n# Epigenetics and its role in cancer therapy","[{\"question\":\"Why does esophageal cancer have poor prognosis despite current treatments?\",\"answer\":\"Despite progress with surgery, chemotherapy, and radiotherapy, effectiveness is still limited in advanced disease and many patients are diagnosed at advanced stages, making outcomes poor.\"},{\"question\":\"Which epigenetic mechanisms are highlighted as important in esophageal cancer?\",\"answer\":\"DNA methylation, histone modifications, and non-coding RNAs are emphasized as key regulatory processes involved in tumor biology.\"},{\"question\":\"How can epigenetic therapy contribute to treatment options for esophageal cancer?\",\"answer\":\"Epigenetic therapies modulate gene expression without changing the DNA sequence, influencing cancer processes such as proliferation, apoptosis, and metastasis, and may provide new therapeutic targets and biomarkers.\"}]","Advances in epigenetic therapy for esophageal cancer | PDF",1790117277,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f792a49def3086cddd14f9668481b7cf.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52829fd769deb604dbf8cf741c5a9444.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f398211a427539f7e24dea738dd29f33.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05d3946541b9a1e1901d8bd6f7a3cb0d.webp",980,1306]